GENOSKIN has been selected on November 2011 to enter, by the end of 2012, the Centre Pierre Potier, a business incubator dedicated to biotech companies.
GENOSKIN and the CNRS have signed an agreement that offers GENOSKIN the opportunity to access, on an exclusive basis, to biosafety level 2 facilities.